LONDON & TOKYO—Heptares Therapeutics’ co-founder and
chief scientific officer, Fiona Marshall, was recently awarded the 2017 John Daly Lecture Award, which is granted every year by the National Institutes of Health, for her contributions to GPCR drug discovery. In conjunction with the award,
Marshall was invited to give the 9th Annual John Daly Memorial Lecture, where she discussed how Heptares’ GPCR stabilization technologies
have produced important information regarding GPCR structure and function, as well as novel molecules for drug development.

“I am delighted and honored to be recognized personally through this award,” said Marshall. “I’ve had the great fortune to
work with some extremely talented people during my career, whose guidance and contributions have been crucial to the direction my research has taken. The
success that Heptares has achieved over the past decade is testament to that influence and this award is further recognition of the team’s excellent
work.”